EXPRESSION OF FGFR 3 PROTEIN AND GENE AMPLIFICATION (FISH) IN DIFFERENT STAGES AND GRADES OF BLADDER CANCER

被引：0
|
作者：
Salem, Hosni
Kamel, Amira
Aboushousha, Tarek
Hammam, Olfat
El-Hindawi, Ali
机构：
来源：
JOURNAL OF UROLOGY | 2017年 / 197卷 / 04期
关键词：
D O I：
10.1016/j.juro.2017.02.2013
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP65-19
引用
收藏
页码：E861 / E861
页数：1
相关论文
共 50 条
  • [41] DIFFERENTIAL HYPOMETHYLATION OF THE C-MYC PROTOONCOGENE IN BLADDER CANCERS AT DIFFERENT STAGES AND GRADES
    DELSENNO, L
    MAESTRI, I
    PIVA, R
    HANAU, S
    REGGIANI, A
    ROMANO, A
    RUSSO, G
    JOURNAL OF UROLOGY, 1989, 142 (01): : 146 - 149
  • [42] Different Gene Expression and Activity Pattern of Antioxidant Enzymes in Bladder Cancer
    Wieczorek, Edyta
    Jablonowski, Zbigniew
    Tomasik, Bartlomiej
    Gromadzinska, Jolanta
    Jablonska, Ewa
    Konecki, Tomasz
    Fendler, Wojciech
    Sosnowski, Marek
    Wasowicz, Wojciech
    Reszka, Edyta
    ANTICANCER RESEARCH, 2017, 37 (02) : 841 - 848
  • [43] Prognostic Value of FGFR Gene Amplification in Patients with Different Types of Cancer: A Systematic Review and Meta-Analysis
    Chang, Jinjia
    Liu, Xinyang
    Wang, Shanshan
    Zhang, Zhe
    Wu, Zheng
    Zhang, Xiaowei
    Li, Jin
    PLOS ONE, 2014, 9 (08):
  • [44] Upregulation of FGFR3 and HIF-1α expression in muscle invasive bladder cancer
    Warli, Syah Mirsya
    Laksmi, Lidya Imelda
    Safriadi, Ferry
    Umbas, Rainy
    MEDICAL JOURNAL OF INDONESIA, 2019, 28 (01) : 3 - 7
  • [45] Challenges in Prediction of different Cancer Stages using Gene Expression Profile of Cancer Patients
    Bhalla, Sherry
    Sharma, Suresh
    Raghava, Gajendra Pal Singh
    ACM-BCB' 2017: PROCEEDINGS OF THE 8TH ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY,AND HEALTH INFORMATICS, 2017, : 602 - 602
  • [46] Expansion part of phase I study of E7090 in patients with cholangiocarcinoma harboring FGFR2 gene fusion and with gastric cancer harboring FGFR2 gene amplification or FGFR2 protein high expression
    Morizane, Chigusa
    Ueno, Makoto
    Ioka, Tatsuya
    Tajika, Masahiro
    Ikeda, Masafumi
    Yamaguchi, Kensei
    Hara, Hiroki
    Yabusaki, Hiroshi
    Miyamoto, Atsushi
    Iwasa, Satoru
    Muto, Manabu
    Takashima, Tsutomu
    Minashi, Keiko
    Komatsu, Yoshito
    Nishina, Tomohiro
    Nakajima, Takako Eguchi
    Sahara, Takatoshi
    Funasaka, Setsuo
    Yashiro, Masakazu
    Furuse, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [47] FGFR3 MUTATIONS AND THEIR RELATION TO FGFR3 EXPRESSION AND CLINICAL OUTCOME IN A LARGE RADICAL CYSTECTOMY COHORT: IMPLICATIONS FOR ANTI-FGFR3 BLADDER CANCER TREATMENT?
    van Rhijn, Bas
    Mertens, Laura
    Mayr, Roman
    Bostrom, Peter
    Marquez, Mirari
    Zwarthoff, Ellen
    Boormans, Joost
    Abas, Cheno
    van Leenders, Geert
    Gotz, Stefanie
    Bertz, Simone
    Neuzillet, Yann
    Sanders, Joyce
    Broeks, Annegien
    van der Heijden, Michiel
    Jewett, Michael
    Real, Francisco
    Stohr, Robert
    Zlotta, Alexandre
    Eckstein, Markus
    Scoorojebally, Yanish
    Burger, Max
    Otto, Wolfgang
    Radvanyi, Francois
    Sirab, Nanour
    Pouessel, Damien
    van der Kwast, Theo
    Malats, Nuria
    Hartmann, Arndt
    Allory, Yves
    van der Schoot, Deric
    Zuiverloon, Tahlita
    JOURNAL OF UROLOGY, 2019, 201 (04): : E924 - E924
  • [48] FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer
    Neuzillet, Yann
    van Rhijn, Bas W. G.
    Prigoda, Nadia L.
    Bapat, Bharati
    Liu, Liyang
    Bostrom, Peter J.
    Fleshner, Neil E.
    Gallie, Brenda L.
    Zlotta, Alexandre R.
    Jewett, Michael A. S.
    van der Kwast, Theo H.
    VIRCHOWS ARCHIV, 2014, 465 (02) : 207 - 213
  • [49] Analysis of HER2 gene amplification and protein expression using FISH and immunohistochemical technologies
    Qi, J
    Tsongalis, GJ
    Furmaga, W
    Anamani, D
    Mandich, D
    Cartun, R
    Ricci, A
    FASEB JOURNAL, 2003, 17 (05): : A1190 - A1190
  • [50] FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer
    Yann Neuzillet
    Bas W. G. van Rhijn
    Nadia L. Prigoda
    Bharati Bapat
    Liyang Liu
    Peter J. Bostrom
    Neil E. Fleshner
    Brenda L. Gallie
    Alexandre R. Zlotta
    Michael A. S. Jewett
    Theo H. van der Kwast
    Virchows Archiv, 2014, 465 : 207 - 213
12345